Eastern Bank’s Bioventus BVS Stock Holding History

Eastern Bank’s Portfolio BVS Stock Details BVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,697	Closed	-$15.5K	–	1060
2026 Q1	$15.5K	Hold	1,697	–	–	﹤0.01%	766
2025 Q4	$12.6K	Buy	+1,697	New	+$12.2K	﹤0.01%	832

Other funds holding BVS

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

JIC

Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Eastern Bank's BVS Position: Q2 2026 in Review

Eastern Bank sold out of Bioventus (BVS) in Q2 2026, closing a stake of 1,697 shares — an estimated $15.5K sold.

Eastern Bank first reported a position in BVS in Q4 2025 and held it in 2 quarters. The position peaked at $15.5K in Q1 2026. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

Eastern Bank reported no remaining Bioventus position as of Q2 2026 after selling out during the quarter.
Eastern Bank sold 1,697 Bioventus shares in Q2 2026, an estimated $15.5K.
Eastern Bank first reported a position in Bioventus in Q4 2025 and held it in 2 quarters.
Eastern Bank's Bioventus position peaked at $15.5K in Q1 2026.
157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Eastern Bank's 13F filing for Q2 2026, filed 1 Jul 2026.